Effect of Upper- and Lower-limb Exercise Training on Circulating Soluble Adhesion Molecules, hs-CRP and Stress Proteins in Patients with Intermittent Claudication

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 5, 2008, Pages 607-613

  Saxton, J M ^a   Zwierska, I ^a   Hopkinson, K ^b   Espigares, E ^c   Choksy, S ^b   Nawaz, S ^b   Walker, R ^b   Pockley, A G ^b  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Atherosclerosis; Biomarkers; Claudication; Exercise

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARM EXERCISE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CIRCULATION; CONFIDENCE INTERVAL; EVOKED RESPONSE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LEG EXERCISE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TRAINING; WALKING;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; CHAPERONIN 60; DISEASE PROGRESSION; E-SELECTIN; EXERCISE THERAPY; FEMALE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; MALE; MIDDLE AGED; RISK FACTORS; UPPER EXTREMITY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 41549161127     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.12.007     Document Type: Article

References (28)

1. Dormandy J., Mahir M., Ascady G., Balsano F., De Leeuw P., Blombery P., et al. Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) 30 (1989) 50-57
2. Kannel W.B., and McGee D. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 33 (1985) 13-18
3. Leng G.C., Lee A.J., Fowkes F.G., Whiteman M., Dunbar J., Housley E., et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25 (1996) 1172-1181
4. Zwierska I., Walker R.D., Choksy S.A., Male J.S., Pockley A.G., and Saxton J.M. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg 42 (2005) 1122-1130
5. Peter K., Nawroth P., Conradt C., Nordt T., Weiss T., Boehme M., et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol 17 (1997) 505-512
6. De Caterina R., Basta G., Lazzerini G., Dell'Omo G., Petrucci R., Morale M., et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17 (1997) 2646-2654
7. Blann A.D., and McCollum C.N. Circulating ICAM-1 in peripheral arterial disease as a predictor of adverse events. Lancet 351 (1998) 1135
8. Belch J.J., Shaw J.W., Kirk G., McLaren M., Robb R., Maple C., et al. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 95 (1997) 2027-2031
9. Albert M.A., and Ridker P.M. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 1 (1999) 99-104
10. Vainas T., Stassen F.R., de Graaf R., Twiss E.L., Herngreen S.B., Welten R.J., et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 42 (2005) 243-251
11. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
12. Pockley A.G. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 105 (2002) 1012-1017
13. Wick G., Knoflach M., and Xu Q. Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22 (2004) 361-403
14. Pockley A.G. Heat shock proteins as regulators of the immune response. Lancet 362 (2003) 469-476
15. Fiotti N., Giansante C., Ponte E., Delbello C., Calabrese S., Zacchi T., et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 145 (1999) 51-60
16. Jager A., van Hinsbergh V.W., Kostense P.J., Emeis J.J., Nijpels G., Dekker J.M., et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with the risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49 (2000) 485-491
17. Adamopoulos S., Parissis J., Kroupis C., Georgiadis M., Karatzas D., Karavolias G., et al. Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22 (2001) 791-797
18. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 24 (2006) 33-50
19. Pigott R., Dillon L.P., Hemingway I.H., and Gearing A.J. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 187 (1992) 584-589
20. Torzewski J., Torzewski M., Bowyer D.E., Frohlich M., Koenig W., Waltenberger J., et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18 (1998) 1386-1392
21. Goldhammer E., Tanchilevitch A., Maor I., Beniamini Y., Rosenschein U., and Sagiv M. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 100 (2005) 93-99
22. Smith J.K., Dykes R., Douglas J.E., Krishnaswamy G., and Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. J Am Med Assoc 281 (1999) 1722-1727
23. Zwierska I., Walker R.D., Choksy S.A., Male J.S., Pockley A.G., and Saxton J.M. Relative tolerance to upper- and lower-limb aerobic exercise in patients with peripheral arterial disease. Eur J Vasc Endovasc Surg 31 (2006) 157-163
24. Brendle D.C., Joseph L.J., Corretti M.C., Gardner A.W., and Katzel L.I. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol 87 (2001) 324-329
25. Pockley A.G., Wu R., Lemne C., Kiessling R., de Faire U., and Frostegård J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension 36 (2000) 303-307
26. Xu Q., Schett G., Perschinka H., Mayr M., Egger G., Oberhollenzer F., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 (2000) 14-20
27. Pockley A.G., Georgiades A., Thulin T., De Faire U., and Frostegard J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42 (2003) 235-238
28. Zhu J., Quyyumi A.A., Wu H., Csako G., Rott D., Zalles-Ganley A., et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 23 (2003) 1055-1059